| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks | Director
2 companies
Dilly Stephen George serves as a See Remarks at CDXS and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 1 buy and 4 sells. Those positions are worth an estimated $1.3M at current prices.
Historically, Dilly Stephen George's trades have earned a strong insider score of 72/100 across 3 rated trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +33.2%.
The biggest single holding is CDXS (~$1.3M). Net of sales, the recent Form 4 record there shows accumulation of 3,404 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 8, 2023 | CDXS Codexis, Inc. | See Remarks | Buy | 58,479 | $1.73 | $100,952.30 | +15.4% | +27.9% | +59.3% | |
| Mar 8, 2023 | CDXS Codexis, Inc. | See Remarks | Sell | 55,075 | $4.58 | $252,211.82 | -12.6% | -42.1% | -19.4% | |
| Mar 19, 2020 | SGMO Sangamo Therapeutics, Inc | Director | Sale+OE | 35,000 | $6.00 | $210,000.00 | -87.5% | - | - | |
| Mar 16, 2020 | SGMO Sangamo Therapeutics, Inc | Director | Sale+OE | 15,000 | $6.02 | $90,261.00 | -75.0% | - | - |